Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados BJMBR (2) Autor Almeida,M.T.A. (1) Brito,J.L.B.C. (1) Costa,P.A. (1) Cristófani,L.M. (1) Lunn,P.G. (1) Maluf,P.T. (1) Odone-Filho,V. (1) Pereira,M.A. (1) Santos-Machado,T.M. (1) Sawaya,A.L. (1) Mais... Palavra-chave Hypoalbuminemia (2) Brown adipose tissue (1) Clenbuterol (1) Cr51-labeled albumin test (1) Gastrointestinal involvement (1) Histiocytosis X (1) Langerhans' cell histiocytosis (1) Protein-energy malnutrition (1) Protein-losing enteropathy (1) Rats (1) SS-2 agonist (1) Mais... Tipo do documento Info:eu-repo/semantics/article (2) Ano 1999 (1) 1998 (1) País Brazil (2) Idioma Inglês (2)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 2 Primeira ... 1 ... Última Disseminated Langerhans' cell histiocytosis and massive protein-losing enteropathy BJMBR Santos-Machado,T.M.; Cristófani,L.M.; Almeida,M.T.A.; Maluf,P.T.; Costa,P.A.; Pereira,M.A.; Brito,J.L.B.C.; Odone-Filho,V.. Symptomatic involvement of the gastrointestinal (GI) tract as a prominent symptom in Langerhans' cell histiocytosis (LCH) is uncommon, occurring in less than 1 to 5% of all cases, even when the disease is in its disseminated form. Up to now, there have been reports of 18 cases of LCH with GI manifestations, including our 2 cases, with diarrhea (77.7%), protein-losing enteropathy (33.3%) and bloody stool being the most frequent findings. The authors present two patients with severe diarrhea and refractory hypoalbuminemia, and with the protein-losing enteropathy documented by Cr51-labeled albumin studies. A review of the literature indicated that the presence of GI symptoms is often associated with systemic disease as well as with poor prognosis, mainly... Tipo: Info:eu-repo/semantics/article Palavras-chave: Langerhans' cell histiocytosis; Histiocytosis X; Gastrointestinal involvement; Protein-losing enteropathy; Hypoalbuminemia; Cr51-labeled albumin test. Ano: 1999 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X1999000900007 Increase in skeletal muscle protein content by the ß-2 selective adrenergic agonist clenbuterol exacerbates hypoalbuminemia in rats fed a low-protein diet BJMBR Sawaya,A.L.; Lunn,P.G.. This investigation examined how the nutritional status of rats fed a low-protein diet was affected when the animals were treated with the ß-2 selective agonist clenbuterol (CL). Males (4 weeks old) from an inbred, specific-pathogen-free strain of hooded rats maintained at the Dunn Nutritional Laboratory were used in the experiments (N = 6 rats per group). CL treatment (Ventipulmin, Boehringer-Ingelheim Ltd., 3.2 mg/kg diet for 2 weeks) caused an exacerbation of the symptoms associated with protein deficiency in rats. Plasma albumin concentrations, already low in rats fed a low-protein diet (group A), were further reduced in CL rats (A = 25.05 ± 0.31 vs CL = 23.64 ± 0.30 g/l, P<0.05). Total liver protein decreased below the level seen in either... Tipo: Info:eu-repo/semantics/article Palavras-chave: Protein-energy malnutrition; Rats; Clenbuterol; Hypoalbuminemia; Brown adipose tissue; SS-2 agonist. Ano: 1998 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X1998000600015 Registros recuperados: 2 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco